Back to Search
Start Over
AbbVie to acquire Landos Biopharma got $20.42 per share in cash
- Source :
- The Fly. March 25, 2024
- Publication Year :
- 2024
-
Abstract
- AbbVie (ABBV) and Landos Biopharma (LABP) announced a definitive agreement under which AbbVie will acquire Landos. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist with a bimodal [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.787648150